We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Smith & Nephew Plc | LSE:SN. | London | Ordinary Share | GB0009223206 | ORD USD0.20 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 966.80 | 967.20 | 967.60 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Ortho,prosth,surg Appl,suply | 5.55B | 263M | 0.3011 | 32.13 | 8.45B |
From Apr 2021 to Apr 2024
TIDMSN.
RNS Number : 7324Y
Smith & Nephew Plc
14 May 2021
SMITH & NEPHEW PLC
14 May 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Hot Features
Premium
Reason for the notification
Initial notification /Amendment Initial notification
-------------------------------------------------
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
Name Smith & Nephew plc
-------------------------------------------------
LEI 213800ZTMDN8S67S1H61
-------------------------------------------------
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
Description of the financial Smith & Nephew plc ordinary shares of USD
instrument, type of instrument 0.20 each
-------------------------------------------------
Identification code ISIN: GB0009223206
-------------------------------------------------
Nature of the transaction Purchase of ordinary shares through the
Company's Dividend Re-Investment Plan following
the 2020 final dividend payment on 12 May
2021.
-------------------------------------------------
Date of Transaction 2021 - 05 - 12
-------------------------------------------------
Place of Transaction London Stock Exchange (XLON)
-------------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Director Aggregated the transaction the transaction
Name (Position) / PDMR Price Volume information * *
Bradley Cannon 77,295.40344
(President (including
Sports Medicine N/A Single 2,101.64550
& ENT) PDMR GBP15.269779 129.64031 Transaction in ADS') 0.00873%
---------- -------------- ---------- ------------- ----------------- -----------------
Phil Cowdy
(Chief Business
Development
& Corporate N/A Single
Affairs Officer) PDMR GBP15.269779 112.08811 Transaction 45,410.28786 0.00513%
---------- -------------- ---------- ------------- ----------------- -----------------
Myra Eskes
(President N/A Single
APAC Region) PDMR GBP15.269779 197.38513 Transaction 18,332.32816 0.00207%
---------- -------------- ---------- ------------- ----------------- -----------------
Simon Fraser
(President
Advanced Wound N/A Single
Management) PDMR GBP15.269779 92.76422 Transaction 8,615.56333 0.00097%
---------- -------------- ---------- ------------- ----------------- -----------------
Mark Gladwell
(President
Operations N/A Single
& GBS) PDMR GBP15.269779 96.46099 Transaction 96.90438 0.00001%
---------- -------------- ---------- ------------- ----------------- -----------------
Melissa Guerdan
(Chief Quality
& Regulatory N/A Single
Affairs Officer) PDMR GBP15.269779 99.85666 Transaction 9,274.28002 0.00105%
---------- -------------- ---------- ------------- ----------------- -----------------
Skip Kiil
(President N/A Single
Orthopaedics) PDMR GBP15.269779 99.50036 Transaction 12,128.03780 0.00137%
---------- -------------- ---------- ------------- ----------------- -----------------
Catheryn O'Rourke 82,100.55347
(Chief Legal (including
& Compliance N/A Single 5,818.25734
Officer) PDMR GBP15.269779 583.31782 Transaction in ADS') 0.00928%
---------- -------------- ---------- ------------- ----------------- -----------------
Susan Swabey N/A Single
(Company Secretary) PDMR GBP15.269779 190.40720 Transaction 49,416.24672 0.00558%
---------- -------------- ---------- ------------- ----------------- -----------------
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFESESISLIL
(END) Dow Jones Newswires
May 14, 2021 11:00 ET (15:00 GMT)
1 Year Smith & Nephew Chart |
1 Month Smith & Nephew Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
